These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8846012)

  • 21. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
    Koç ON; Gerson SL; Phillips GL; Cooper BW; Kutteh L; Van Zant G; Reece DE; Fox RM; Schupp JE; Tainer N; Lazarus HM
    Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation.
    Purdy MH; Hogan CJ; Hami L; McNiece I; Franklin W; Jones RB; Bearman SI; Berenson RJ; Cagnoni PJ; Heimfeld S
    J Hematother; 1995 Dec; 4(6):515-25. PubMed ID: 8846011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of CD34+ selection and T cell immunodepletion on cord blood hematopoietic progenitors: relevance to stem cell transplantation.
    Laver J; Traycoff CM; Abdel-Mageed A; Gee A; Lee C; Turner C; Srour EF; Abboud M
    Exp Hematol; 1995 Dec; 23(14):1492-6. PubMed ID: 8542936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified method of CD34+ cell determination for peripheral blood progenitor cell transplantation and correlation with clinical engraftment.
    Sandhaus LM; Edinger MG; Tubbs RR; Goormastic M; Baucco PA; Serafino SE; Bolwell BJ
    Exp Hematol; 1998 Jan; 26(1):73-8. PubMed ID: 9430516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood stem cell transplantation in myeloma using CD34 selected cells.
    Johnson RJ; Owen RG; Smith GM; Child JA; Galvin M; Newton LJ; Rawstron A; Major K; Woodhead V; Robinson F; Jack A; Morgan GJ
    Bone Marrow Transplant; 1996 May; 17(5):723-7. PubMed ID: 8733688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of CD34+ hematopoietic progenitor cells.
    Shpall EJ; Jones RB; Bearman SI; Purdy MH; Franklin WA; Heimfeld S; Berenson RJ
    J Hematother; 1994; 3(2):145-7. PubMed ID: 7522899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryopreservation of hematopoietic stem and progenitor cells amplified ex vivo from cord blood CD34+ cells.
    Duchez P; Chevaleyre J; Brunet de la Grange P; Vlaski M; Boiron JM; Wouters G; Ivanovic Z
    Transfusion; 2013 Sep; 53(9):2012-9. PubMed ID: 23227804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expansion of blood CD34+ cells: committed precursor expansion does not affect immature hematopoietic progenitors.
    David S; Boiron JM; Dupouy M; Rice A; Vianes I; Duperray V; Reiffers J
    J Hematother; 1997 Apr; 6(2):151-8. PubMed ID: 9131445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC).
    Vogel W; Scheding S; Kanz L; Brugger W
    Stem Cells; 2000; 18(2):87-92. PubMed ID: 10742380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
    Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
    Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coculture and transplant of purified CD34(+)Lin(-) and CD34(-)Lin(-) cells reveals functional interaction between repopulating hematopoietic stem cells.
    Hess DA; Karanu FN; Levac K; Gallacher L; Bhatia M
    Leukemia; 2003 Aug; 17(8):1613-25. PubMed ID: 12886251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
    Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
    Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Autologous transplantation of hematopoietic precursor cells following CD34 selection].
    Tichelli A; Gratwohl A; Bargetzi M; Nissen C; Wernli M; Herrmann R; Orth B; Signer E; Speck B
    Schweiz Med Wochenschr; 1996 Feb; 126(6):201-6. PubMed ID: 8720723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New consecutive high-dose chemotherapy modality with fractionated blood stem cell support in the treatment of high-risk pediatric solid tumors: a feasibility study.
    Kajiume T; Kawano Y; Takaue Y; Abe T; Watanabe T; Okamoto Y; Makimoto A; Suenaga K; Suzuya H; Sato J; Yokobayashi A; Hashimoto T; Yoshida K; Ishibashi H; Takehara H; Tashiro S; Kuroda Y
    Bone Marrow Transplant; 1998 Jan; 21(2):147-51. PubMed ID: 9489631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haematopoietic reconstitution after autologous transplantation of CD34(+)-selected versus non-selected peripheral blood progenitor cells.
    Wiesneth M; Schreiner T; Sandherr M; Maccari B; Erne E; Bischof C; Frickhofen N; von Schilling C; Kubanek B
    Beitr Infusionsther Transfusionsmed; 1997; 34():133-8. PubMed ID: 9356664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
    Han X; Shi Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
    Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
    Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.